IMP型和vim型碳青霉烯酶的遗传多样性、生化特性、流行病学及检测方法。

IF 19.3 1区 医学 Q1 MICROBIOLOGY
Rémy A Bonnin,Agnès B Jousset,Aymeric Jacquemin,Cécile Emeraud,Delphine Girlich,Thierry Naas,Laurent Dortet
{"title":"IMP型和vim型碳青霉烯酶的遗传多样性、生化特性、流行病学及检测方法。","authors":"Rémy A Bonnin,Agnès B Jousset,Aymeric Jacquemin,Cécile Emeraud,Delphine Girlich,Thierry Naas,Laurent Dortet","doi":"10.1128/cmr.00129-23","DOIUrl":null,"url":null,"abstract":"SUMMARYMetallo-beta-lactamases are an ever-growing problem. Since the discovery of the beta-lactamase of Bacillus cereus in the late 1960s, many class B beta-lactamases have been reported, with three main families being NDM-, IMP-, and VIM-like. IMP- and VIM-like carbapenemases have been identified in a wide variety of Gram-negative bacteria. VIM-type carbapenemases are widely distributed, primarily represented by two main clusters, VIM-1 and VIM-2, and have been found in both Enterobacterales and non-fermenters. IMP-type carbapenemases are characterized by a significant genetic diversity and low identity between subgroups. This carbapenemase is more prevalent in Asia but has been identified globally, in both Enterobacterales and non-fermenters, as observed for VIM-type carbapenemases. The genetic diversity of IMP- and some VIM-type carbapenemases limits their detection. This review aims to discuss the genetic diversity, epidemiology, and biochemical characteristics of VIM- and IMP-type carbapenemases. It also evaluates the efficacy of commercially available detection tests and the in vitro activity of recently developed inhibitors.","PeriodicalId":10378,"journal":{"name":"Clinical Microbiology Reviews","volume":"27 1","pages":"e0012923"},"PeriodicalIF":19.3000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases.\",\"authors\":\"Rémy A Bonnin,Agnès B Jousset,Aymeric Jacquemin,Cécile Emeraud,Delphine Girlich,Thierry Naas,Laurent Dortet\",\"doi\":\"10.1128/cmr.00129-23\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"SUMMARYMetallo-beta-lactamases are an ever-growing problem. Since the discovery of the beta-lactamase of Bacillus cereus in the late 1960s, many class B beta-lactamases have been reported, with three main families being NDM-, IMP-, and VIM-like. IMP- and VIM-like carbapenemases have been identified in a wide variety of Gram-negative bacteria. VIM-type carbapenemases are widely distributed, primarily represented by two main clusters, VIM-1 and VIM-2, and have been found in both Enterobacterales and non-fermenters. IMP-type carbapenemases are characterized by a significant genetic diversity and low identity between subgroups. This carbapenemase is more prevalent in Asia but has been identified globally, in both Enterobacterales and non-fermenters, as observed for VIM-type carbapenemases. The genetic diversity of IMP- and some VIM-type carbapenemases limits their detection. This review aims to discuss the genetic diversity, epidemiology, and biochemical characteristics of VIM- and IMP-type carbapenemases. It also evaluates the efficacy of commercially available detection tests and the in vitro activity of recently developed inhibitors.\",\"PeriodicalId\":10378,\"journal\":{\"name\":\"Clinical Microbiology Reviews\",\"volume\":\"27 1\",\"pages\":\"e0012923\"},\"PeriodicalIF\":19.3000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Microbiology Reviews\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1128/cmr.00129-23\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1128/cmr.00129-23","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

金属-内酰胺酶是一个日益严重的问题。自20世纪60年代末蜡样芽孢杆菌的β -内酰胺酶被发现以来,已报道了许多B类β -内酰胺酶,主要有NDM-、IMP-和VIM-like三个家族。IMP-和vim样碳青霉烯酶已在多种革兰氏阴性菌中发现。vim型碳青霉烯酶分布广泛,主要以VIM-1和VIM-2两个主要簇为代表,在肠杆菌和非发酵菌中均有发现。imp型碳青霉烯酶具有显著的遗传多样性和亚群之间的低同一性。这种碳青霉烯酶在亚洲更为普遍,但在全球范围内已被发现,在肠杆菌和非发酵菌中都有发现,如在vim型碳青霉烯酶中观察到的那样。IMP-和一些vim型碳青霉烯酶的遗传多样性限制了它们的检测。本文综述了VIM型和imp型碳青霉烯酶的遗传多样性、流行病学和生化特性。它还评估了市售检测试验的功效和最近开发的抑制剂的体外活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Genetic diversity, biochemical properties, epidemiology, and detection methods of IMP- and VIM-type carbapenemases.
SUMMARYMetallo-beta-lactamases are an ever-growing problem. Since the discovery of the beta-lactamase of Bacillus cereus in the late 1960s, many class B beta-lactamases have been reported, with three main families being NDM-, IMP-, and VIM-like. IMP- and VIM-like carbapenemases have been identified in a wide variety of Gram-negative bacteria. VIM-type carbapenemases are widely distributed, primarily represented by two main clusters, VIM-1 and VIM-2, and have been found in both Enterobacterales and non-fermenters. IMP-type carbapenemases are characterized by a significant genetic diversity and low identity between subgroups. This carbapenemase is more prevalent in Asia but has been identified globally, in both Enterobacterales and non-fermenters, as observed for VIM-type carbapenemases. The genetic diversity of IMP- and some VIM-type carbapenemases limits their detection. This review aims to discuss the genetic diversity, epidemiology, and biochemical characteristics of VIM- and IMP-type carbapenemases. It also evaluates the efficacy of commercially available detection tests and the in vitro activity of recently developed inhibitors.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical Microbiology Reviews
Clinical Microbiology Reviews 医学-微生物学
CiteScore
54.20
自引率
0.50%
发文量
38
期刊介绍: Clinical Microbiology Reviews (CMR) is a journal that primarily focuses on clinical microbiology and immunology.It aims to provide readers with up-to-date information on the latest developments in these fields.CMR also presents the current state of knowledge in clinical microbiology and immunology.Additionally, the journal offers balanced and thought-provoking perspectives on controversial issues in these areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信